In Conversation

India Pharma Report 2024
Latest Reports
India Pharma Report 2024
- 2024
Rising per capita GDP, enhanced purchasing power, and a surge in inward-bound FDI flows mean that the Indian economy is on its strongest footing in generations. India’s leading industries – notably its life science sector – are reaping the rewards and anticipating rapid market growth. The USD 65 billion Indian pharma market is predicted to…
InFigures Latin America 2024
Latest Reports
InFigures Latin America 2024
- 2024
PharmaBoardroom’s latest report, InFigures: Latin America 2024 features up-to-date datasets from the region’s leading pharma markets and regional production hubs. The combined Latin America and Caribbean market of USD 197 billion looks set to be the fastest growing in the world over the next few years. IQVIA estimates that the Latin American pharma market will…
Portugal Pharma Report
Latest Reports
Portugal Pharma Report
- 2024
Healthcare & Life Sciences Review Portugal 2024 – drawing from over 30 interviews with key stakeholders from industry, government, academia, and hospitals – paints a picture of a nation and a sector not without its challenges, but gradually carving out some highly promising niches. Topics covered in this comprehensive and up-to-date new report include deep…
Morocco Pharma Report 2023
Latest Reports
Morocco Pharma Report 2023
- 2023
Morocco, and its healthcare sector, have reached a pivotal moment. The North African nation is currently implementing the most ambitious, far-reaching, and comprehensive health system reorganization in its history along with a major shake-up of the regulatory frameworks governing the country’s local pharmaceuticals industry. All of this is occurring within the context of a cross-industry…
UAE Pharma Report 2023
Latest Reports
UAE Pharma Report 2023
- 2023
Long considered a destination of choice for life science multinationals seeking to tap into the latent potential of Middle Eastern markets, the United Arab Emirates’ pharmaceuticals, medtech and healthcare sectors have all been exhibiting significant growth momentum in the post-pandemic period. This comprehensive new report, based on interviews with government officials, KOLs, representatives of multinational…
Hong Kong & The Greater Bay Area Pharma Report 2023
Latest Reports
Hong Kong & The Greater Bay Area Pharma Report 2023
- 2023
Post-COVID and with a national-level strategy in place to bolster its traditional strengths as well as spearhead entry into new sectors, Hong Kong has reason for optimism once again. One of two special administrative regions (SARs) in southern China with separate laws and regulations to the rest of the country, Hong Kong has had to…
Belgium Pharma Report 2023
Latest Reports
Belgium Pharma Report 2023
- 2023
It is undeniable that Belgium holds a strong position as a vibrant life sciences hub at the heart of Europe. Although the country itself represents only a mid-sized marketplace, Belgium boasts a robust environment that fosters multinational drug makers as well as home-grown biotechs and is replete with singular expertise. From its strategic position at…
Greece Pharma Report 2023
Latest Reports
Greece Pharma Report 2023
- 2023
Thanks to a more stable macroeconomic and political footing than at any time in the past 15 years, Greeks once more have cause for cautious optimism about their country’s direction of travel. Many of the half a million educated young people who left the country in search of opportunities elsewhere during the crisis are returning,…
Latin America Pharma Report 2023
Latest Reports
Latin America Pharma Report 2023
- 2023
This exclusive new report, bringing together stakeholders from across the Latin American healthcare and life sciences ecosystem, shines a light on a continent, and an industry, poised for increased global relevance in the coming years. While economic and political uncertainty remain facts of life in LatAm, the region also has all the fundamentals of a…
InFigures Asia-Pacific 2023
Latest Reports
InFigures Asia-Pacific 2023
- 2023
PharmaBoardroom’s latest report, InFigures: Asia Pacific 2023 features up-to-date datasets from the region’s leading pharma markets and regional innovation hubs. Covering everything from population health to market growth, company rankings, innovation footprints, IPOs, and drug approvals, as well as market-specific executive insight from the PharmaBoardroom archives, this exclusive new report is an excellent jumping-off point…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here